Actualidad

/
/
Masimo Reports Third Quarter 2016 Financial Results

Masimo Reports Third Quarter 2016 Financial Results

02/11/2016

Q3 2016 Highlights (compared to Q3 2015):

Total revenue, including royalties, rose 9.9% to $167.6 million

Product revenue rose 10.8% to $160.3 million

Masimo rainbow® revenue rose 5.0% to $18.0 million

45,800 SET® and rainbow® SET®
oximeters were shipped

GAAP net income of $27.8 million, or $0.52 per diluted share versus
$19.3 million, or $0.36 per diluted share in the year-ago period

IRVINE, Calif.–(BUSINESS WIRE)–Nov. 2, 2016–
Masimo (NASDAQ: MASI) today announced its financial results for the
third quarter ended …

Más información: Masimo Reports Third Quarter 2016 Financial Results

Comparte:

El contenido de este sitio web está destinado únicamente a profesionales médicos/sanitarios.

Es posible que los productos contenidos en este sitio no estén disponibles en todos los mercados, ya que la disponibilidad está sujeta a prácticas normativas y médicas en mercados individuales.